Darnytsia Won the Exporter of the Year Nomination at the Eurasian Pharmaceutical Summit

Darnytsia Pharmaceutical Company received the prestigious Eurasian Pharma Awards-2024 award in the Exporter of the Year nomination.

The award ceremony took place on 17 September 2024, within the framework of the Eurasian Pharmaceutical Summit in Tashkent (Uzbekistan).

The Eurasian Pharmaceutical Summit is an annual event that gathers more than 400 representatives of pharmaceutical companies operating in the markets of Central Asia, the Caucasus and Eastern Europe.
During the event, a competition for the Eurasian Pharma Awards is held. Leading international and local pharmaceutical manufacturing companies, distributors and pharmacy chains participate in it. This year, the fight took place in 10 nominations, including the Exporter of the Year nomination.

The winners were determined by an expert jury based on the submitted questionnaires and an in-depth analysis of the activities of the competition participants.

“Our victory in the Exporter of the Year nomination confirms that we are on the right track. Darnytsia produces medicines that meet international quality and safety standards. At the same time, such a prestigious award stimulates us to move forward even more persistently and confidently. We will continue to work on innovation, expanding our range and improving our processes. We strive to make our medicines available not only in Ukraine, but also outside of Ukraine,” Anna Pavliuk-Havrylova, Head of the Department of International Registration and Market Expansion at Darnytsia Pharmaceutical Company, said.

We will remind you that Darnytsia high-quality and safe medicines are already trusted in 20 countries of the world.